![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by Staff Writers Beijing (AFP) Nov 12, 2018
Chinese vaccine manufacturers who falsify test results or break other rules could be fined up to $720,000 under a new law proposed after a scandal that fulled public fears over domestically made medicine. The law would regulate areas including production, distribution and use of vaccines, according to a draft posted Sunday on the website of China's market regulator. The country was earlier this year rocked by a scandal that saw a manufacturer of rabies vaccines fabricating records. While authorities say the affected vaccines did not enter the market, the case provoked outrage from consumers fed up with recurring product safety scandals, particularly in pharmaceuticals. Under the proposed law, those who flout the rules can be fined up to 5.0 million yuan ($720,000) for offences including submitting false test results, not recalling problematic batches and "other serious illegal acts". "Those who participate in illegal behaviour, shield or connive with violators, hide the facts through fabrication, or impede investigation will receive severe punishment," the draft said. This is the first time a law has explicitly targeted vaccines, which were previously covered by regulations controlling medicine. The authorities last month slapped the Changchun Changsheng Biotechnology company with a massive $1.3 billion in penalties over the rabies vaccine scandal. The firm's chairwoman and 14 other people were arrested in connection with the affair in July while more than a dozen national, provincial and local officials were sacked, including several senior officials from the drug regulatory agency. China is regularly hit by scandals involving sub-par or toxic food, drugs and other products, despite repeated promises by the government to address the problem. After the latest case came to light, the authorities announced a nationwide inspection of laboratories producing vaccines. But many Chinese parents say they no longer have confidence in the medicines administered to their children. During the height of the scandal, clinics in Hong Kong saw a run on their vaccine stocks by worried parents from the mainland. President Xi Jinping described the vaccine debacle as "vile" and "shocking" in July while Premier Li Keqiang said the latest case had crossed a "line of human ethics". In August, India ordered a recall of rabies vaccines made by Changchun Changsheng and complained that it only found out about possible problems through media reports.
![]() ![]() Use of monkeys for medical research hits all-time high Washington (UPI) Nov 5, 2018 Use of monkeys in medical research hit an all-time high in 2017, according to United States Department of Agriculture data. Last year, scientists used close to 76,000 primates for research, up by 22 percent from 2015 and 6 percent in 2008, according to a USDA report. Experts think primates are better animals for testing of drugs and study of diseases than mice or dogs because of their genetic and physical similarity to humans. "I think the numbers are trending up because these animals gi ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |